McClure MO - Search Results

1

Pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers.

Ashby J, Garvey L, Erlwein OW, Lamba H, Weston R, Legg K, Latch N, McClure MO, Dickinson L, D'Avolio A, Back D, Winston A. Ashby J, et al. Among authors: mcclure mo. J Antimicrob Chemother. 2011 Jun;66(6):1340-5. doi: 10.1093/jac/dkr093. Epub 2011 Mar 15. J Antimicrob Chemother. 2011. PMID: 21406434 Clinical Trial.

2

The effects of a nucleoside-sparing antiretroviral regimen on the pharmacokinetics of ritonavir-boosted darunavir in HIV type-1-infected patients.

Garvey L, Latch N, Erlwein OW, Mackie NE, Walsh J, Scullard G, McClure MO, Dickinson L, Back D, Winston A. Garvey L, et al. Among authors: mcclure mo. Antivir Ther. 2010;15(2):213-8. doi: 10.3851/IMP1517. Antivir Ther. 2010. PMID: 20386076 Clinical Trial.

3

Alterations in cerebrospinal fluid chemokines are associated with maraviroc exposure and in vivo metabolites measurable by magnetic resonance spectroscopy.

Vera JH, Garvey LJ, Allsop JM, Kaye S, McClure MO, Back D, Taylor-Robinson SD, Winston A. Vera JH, et al. Among authors: mcclure mo. HIV Clin Trials. 2012 Jul-Aug;13(4):222-7. doi: 10.1310/hct1304-222. HIV Clin Trials. 2012. PMID: 22849963

4

Progress and prospects: foamy virus vectors enter a new age.

Erlwein O, McClure MO. Erlwein O, et al. Among authors: mcclure mo. Gene Ther. 2010 Dec;17(12):1423-9. doi: 10.1038/gt.2010.95. Epub 2010 Jul 15. Gene Ther. 2010. PMID: 20631802 Review.

5

Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection.

Hamlyn E, Hickling S, Porter K, Frater J, Phillips R, Robinson M, Mackie NE, Kaye S, McClure M, Fidler S; SPARTAC Investigators. Hamlyn E, et al. AIDS. 2012 Apr 24;26(7):887-90. doi: 10.1097/QAD.0b013e328351e721. AIDS. 2012. PMID: 22313951

6

Xenotropic murine leukaemia virus-related virus (XMRV) does not cause chronic fatigue.

Robinson MJ, Erlwein O, McClure MO. Robinson MJ, et al. Among authors: mcclure mo. Trends Microbiol. 2011 Nov;19(11):525-9. doi: 10.1016/j.tim.2011.08.005. Epub 2011 Oct 4. Trends Microbiol. 2011. PMID: 21978843

7

Sequences in pol are required for transfer of human foamy virus-based vectors.

Erlwein O, Bieniasz PD, McClure MO. Erlwein O, et al. Among authors: mcclure mo. J Virol. 1998 Jul;72(7):5510-6. doi: 10.1128/JVI.72.7.5510-5516.1998. J Virol. 1998. PMID: 9621007 Free PMC article.

8

Differential susceptibility of retroviruses to nucleoside analogues.

Rosenblum LL, Patton G, Grigg AR, Frater AJ, Cain D, Erlwein O, Hill CL, Clarke JR, McClure MO. Rosenblum LL, et al. Among authors: mcclure mo. Antivir Chem Chemother. 2001 Mar;12(2):91-7. doi: 10.1177/095632020101200202. Antivir Chem Chemother. 2001. PMID: 11527046 Free article.

9

Cell-cycle dependence of foamy virus vectors.

Patton GS, Erlwein O, McClure MO. Patton GS, et al. Among authors: mcclure mo. J Gen Virol. 2004 Oct;85(Pt 10):2925-2930. doi: 10.1099/vir.0.80210-0. J Gen Virol. 2004. PMID: 15448354

10

Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection.

Hamlyn E, Ewings FM, Porter K, Cooper DA, Tambussi G, Schechter M, Pedersen C, Okulicz JF, McClure M, Babiker A, Weber J, Fidler S; INSIGHT SMART and SPARTAC Investigators. Hamlyn E, et al. PLoS One. 2012;7(8):e43754. doi: 10.1371/journal.pone.0043754. Epub 2012 Aug 31. PLoS One. 2012. PMID: 22952756 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page